These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 11719247)

  • 1. Transglutaminase-dependent formation of protein aggregates as possible biochemical mechanism for polyglutamine diseases.
    Violante V; Luongo A; Pepe I; Annunziata S; Gentile V
    Brain Res Bull; 2001 Oct-Nov 1; 56(3-4):169-72. PubMed ID: 11719247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical mechanisms for a possible involvement of the transglutaminase activity in the pathogenesis of the polyglutamine diseases: minireview article.
    Pepe I; Occhino E; Cella G; Luongo A; Guardascione F; Gentile V
    Amino Acids; 2004 Jul; 26(4):431-4. PubMed ID: 15290350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The advances in research on phosphorylation of polyglutamine disease].
    Zhou YF; Jiang H; Tang JG; Tang BS
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Aug; 25(4):414-7. PubMed ID: 18683139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transglutaminase-catalyzed post-translational modifications of proteins in the nervous system and their possible involvement in neurodegenerative diseases.
    De Vivo G; Gentile V
    CNS Neurol Disord Drug Targets; 2008 Oct; 7(4):370-5. PubMed ID: 18991665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the transglutaminase enzymes in the nervous system and their possible involvement in neurodegenerative diseases.
    De Vivo G; Di Lorenzo R; Ricotta M; Gentile V
    Curr Med Chem; 2009; 16(36):4767-73. PubMed ID: 19929789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysine-rich histone (H1) is a lysyl substrate of tissue transglutaminase: possible involvement of transglutaminase in the formation of nuclear aggregates in (CAG)(n)/Q(n) expansion diseases.
    Cooper AJ; Wang J; Pasternack R; Fuchsbauer HL; Sheu RK; Blass JP
    Dev Neurosci; 2000; 22(5-6):404-17. PubMed ID: 11111157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transglutaminase 6 interacts with polyQ proteins and promotes the formation of polyQ aggregates.
    Guan WJ; Xia KD; Ma YT; Liu YT; Shi YT; Jiang H; Shen L; Xia K; Li JD; Tang BS; Wang JL
    Biochem Biophys Res Commun; 2013 Jul; 437(1):94-100. PubMed ID: 23800413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CREB-binding protein sequestration by expanded polyglutamine.
    McCampbell A; Taylor JP; Taye AA; Robitschek J; Li M; Walcott J; Merry D; Chai Y; Paulson H; Sobue G; Fischbeck KH
    Hum Mol Genet; 2000 Sep; 9(14):2197-202. PubMed ID: 10958659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible Role of the Polyglutamine Elongation in Evolution of Amyloid-Related Evolvability.
    Hashimoto M; Ho G; Takamatsu Y; Wada R; Sugama S; Takenouchi T; Masliah E; Waragai M
    J Huntingtons Dis; 2018; 7(4):297-307. PubMed ID: 30372687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptides containing glutamine repeats as substrates for transglutaminase-catalyzed cross-linking: relevance to diseases of the nervous system.
    Kahlem P; Terré C; Green H; Djian P
    Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14580-5. PubMed ID: 8962095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transglutaminase and diseases of the central nervous system.
    Hoffner G; Djian P
    Front Biosci; 2005 Sep; 10():3078-92. PubMed ID: 15970562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms responsible for the involvement of tissue transglutaminase in human diseases: Celiac Disease.
    Amantea G; Cammarano M; Zefferino L; Martin A; Romito G; Piccirillo M; Gentile V
    Front Biosci; 2006 Jan; 11():249-55. PubMed ID: 16146729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Ubiquitin Proteasome Pathway with Traditional Chinese Medicine for Treatment of Spinocerebellar Ataxia Type 3.
    Chen IC; Chang CN; Chen WL; Lin TH; Chao CY; Lin CH; Lin HY; Cheng ML; Chiang MC; Lin JY; Wu YR; Lee-Chen GJ; Chen CM
    Am J Chin Med; 2019; 47(1):63-95. PubMed ID: 30612452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiological roles of transglutaminase - catalyzed reactions in the pathogenesis of human diseases.
    Martin A; De Vivo G; Iannaccone M; Stefanile A; Serretiello E; Gentile V
    Inflamm Allergy Drug Targets; 2012 Aug; 11(4):278-84. PubMed ID: 22680626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of inclusion bodies in (CAG)n/Qn-expansion diseases with special reference to the role of tissue transglutaminase and to selective vulnerability.
    Cooper AJ; Sheu KF; Burke JR; Strittmatter WJ; Gentile V; Peluso G; Blass JP
    J Neurochem; 1999 Mar; 72(3):889-99. PubMed ID: 10037459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyglutamine tract expansion of the androgen receptor in a motoneuronal model of spinal and bulbar muscular atrophy.
    Piccioni F; Simeoni S; Andriola I; Armatura E; Bassanini S; Pozzi P; Poletti A
    Brain Res Bull; 2001 Oct-Nov 1; 56(3-4):215-20. PubMed ID: 11719253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of spinocerebellar ataxia type 1, dentatorubropallidoluysian atrophy, and Machado-Joseph disease mutations in a large group of spinocerebellar ataxia patients.
    Silveira I; Lopes-Cendes I; Kish S; Maciel P; Gaspar C; Coutinho P; Botez MI; Teive H; Arruda W; Steiner CE; Pinto-Júnior W; Maciel JA; Jerin S; Sack G; Andermann E; Sudarsky L; Rosenberg R; MacLeod P; Chitayat D; Babul R; Sequeiros J; Rouleau GA
    Neurology; 1996 Jan; 46(1):214-8. PubMed ID: 8559378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of transglutaminase-catalyzed reactions in the post-translational modifications of proteins responsible for immunological disorders.
    De Vivo G; Martin A; Trotta T; Gentile V
    Inflamm Allergy Drug Targets; 2008 Mar; 7(1):24-9. PubMed ID: 18473897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Neuropathology of Spinocerebellar Ataxia Type 3/Machado-Joseph Disease.
    Koeppen AH
    Adv Exp Med Biol; 2018; 1049():233-241. PubMed ID: 29427106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transglutaminase potentiates ligand-dependent proteasome dysfunction induced by polyglutamine-expanded androgen receptor.
    Mandrusiak LM; Beitel LK; Wang X; Scanlon TC; Chevalier-Larsen E; Merry DE; Trifiro MA
    Hum Mol Genet; 2003 Jul; 12(13):1497-506. PubMed ID: 12812978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.